Feng Zhang: From ESL to Revolution
Credited with the development of transformative technologies such as CRISPR, the revolutionary genome editing tool, Feng Zhang’s resume is littered with the names of biomedical science’s top honors: He is the recipient of the Gairdner Award, the Albany Medical Center Prize, the Lemelson-MIT Prize, and the Blavatnik National Award for Young Scientists, to name just a few.
Despite this proliferation, however, the Vilcek Prize for Creative Promise holds a special place in Feng’s heart. “This prize is a recognition of all the Americans who welcomed an immigrant into their society with open arms,” he says.
Of those, Feng recalls many. He emigrated from China at the age of 11 and enrolled at Callanan Middle School in Des Moines, Iowa. The state was then accepting a high volume of immigrants and refugees, and Feng’s school had a strong English as a Second Language program, helmed by a nurturing teacher he remembers fondly: “Marilyn Ritz, R-I-T-Z.”
It was also at Callanan that his interest in biological research was first sparked. Feng had always been interested in technology—“everything from space shuttles to rockets to robots”—and he relished opportunities to take things apart in order to see how they worked. He had, however, found biology and life sciences to be boring. “It was mostly about memorizing things, phylogeny or which leaf came from which tree,” he says. “It wasn’t so interesting to me.”
It was not until he joined a Saturday enrichment program in molecular biology that his view changed. Led by another teacher Feng recalls with deep appreciation, Ed Pilkington, he discovered that modern biology was a dynamic field with the potential to change people’s lives. Under Pilkington’s guidance, he learned how to extract DNA from strawberries, how to visualize it in a gel, and the scientific basis behind the movie Jurassic Park.
“Taking that class with Mr. Pilkington, I realized that biology is something that you can now engineer, because we’re starting to unravel the fundamental building principles of biology,” Feng says. “For someone who likes to take things apart and put them back together again, that is really exciting.”
Remembering his excitement, Pilkington contacted Feng a few years later when a volunteer opportunity at a gene therapy lab opened up at a nearby medical hospital complex. Feng was accepted into the program as a sophomore and began his training in molecular biology under the mentorship of Dr. John Levy. Over the next few years, Feng spent hours each day after school in the lab, absorbing a practical education on scientific research and performing experiments of his own.
With a strong record of scientific accomplishment already under his belt, Feng went on to Harvard after graduating high school, where he studied chemistry and physics while working in the labs of biophysicists Don Wiley and Xiaowei Zhuang. During his time at Harvard, Feng also witnessed firsthand the debilitating effects of depression in a close friend. Before, like many people, Feng believed that psychiatric disease was something that could be overcome with mental fortitude. “The experience with my friend taught me that mental illness is really something physical,” Feng says. “There is something that’s not working correctly in the brain and we need to learn more about what is happening in order to be able to help them.”
Upon graduation, he decided to devote his doctoral research at Stanford University to the study of the brain, joining the lab of Karl Deisseroth, a bioengineer and a psychiatrist who was hoping to develop new molecular technologies to help neuroscientists study the brain more efficiently. There, Feng was tasked with finding ways to express light-sensitive microbial proteins in neuron cells. Using viral vector techniques he learned in the gene therapy lab of John Levy, Feng was able to insert the genes for channelrhodopsin-2—and, later, halorhodopsin—into brain cells.
These techniques formed an important basis for optogenetics, a method of controlling brain cells using light. Since then, it has enabled a finer analysis of brain circuitry and a greater understanding of how different parts of the brain are involved in functions like sleep, arousal, memory, and affective disorders.
Feng’s contributions were a technical coup, but he hoped to further refine them. Starting his own lab at MIT in 2011—where he is now the James and Patricia Poitras Professor in Neuroscience at McGovern Institute for Brain Research and a Core Institute Member of the Broad Institute—Feng sought a better way to edit mammalian genomes, and in so doing, laid the groundwork for his next major accomplishment: harnessing CRISPR, a bacterial defense mechanism, to edit the genomes of living cells.
Feng had been experimenting with proteins called zinc finger nucleases and TALENs, and although he was successful in using them as a method of genetic engineering, he was aware that they were too cumbersome to be of widespread use. During a lecture by a colleague, Feng heard about a natural genetic toolkit that some bacteria use to fend off invading viruses and realized that it could be co-opted for editing genes.
The resulting CRISPR-Cas9 genome editing module is elegantly simple—Feng compares it to using the search function in a Word document. To fix a typo in a Word document, one would use a search function to locate the specific typo, and then use the cursor to delete or correct the error. “The way CRISPR works is that you can design a specific RNA sequence to match the typo,” Feng explains, “and the system will go into the DNA and search along the genome until it [finds a match].”
When a match is made, the enzyme Cas9 then cleaves to the matching sequence in the genome and inactivates it. Cells stitch the genome back together using DNA repair mechanisms that sometimes rely on a reference template provided by researchers. By introducing a template containing a desired sequence, researchers can direct the edit—eliminating, for example, disease-causing mutations. Because guide RNA sequences can be designed to target any gene of interest, this engineered CRISPR-Cas9 system represents a powerful tool to edit genomes with breathtaking ease.
In 2013, Feng published a landmark paper in Science demonstrating the use of engineered CRISPR-Cas9 to edit the genomes of living mouse and human cells. Since then, a staggering array of potential uses for the toolkit have become evident; it can be called, without risk of hyperbole, a revolutionary tool capable of changing many fields of science.
It allows for greater understanding of the human genome and how it is affected by mutations, as well as the creation of possible therapeutics. In agriculture, it has the potential to create crops with greater yields or resistance to disease or drought. It also has diagnostic possibilities, as the toolkit can quickly and inexpensively diagnose bacterial infections, potentially eliminating the need for the broad-spectrum antibiotics that have been contributing to the rise of antibiotic resistance.
Because of these myriad uses, Feng hopes to make the tools widely accessible to the scientific community. Like the many people who welcomed him as a newcomer and gave him opportunities to succeed, Feng delights in helping others realize their potential. “Every person has their own creativity and their own way of thinking about problems,” Feng says. “That’s part of the joy too, seeing how you can help people realize an even bigger impact.”
Announcing the 2018 Vilcek Prizewinners
Congratulations to the remarkable biomedical scientists and professionals in the architecture field who have been awarded the 2018 Vilcek Prizes. Learn more about their incredible accomplishments:
In Support of DACA
2017 was a tumultuous year for immigration policy in the United States, with several controversial restrictions issued by the new administration. As former refugees and green card holders, our founders Jan and Marica Vilcek share their thoughts on these policies.